Remarkably, FGF19 was found downregulated in cases of chronic diarrhoea caused by bile acid malabsorption [35], thus this gene could be an indicator of increased risk of diarrhoea in cancer patients taking gefitinib. This evidence concerns the gene FGF19 and Diarrhea.